NIMH Chemical Synthesis and Drug Supply Program

Compounds Catalog

Click the NIMH number to see more information about the compound.
Click the order button to order that compound.
Type within the boxes at the top of any column to search for items in the catalog.

Download Catalog

Compounds Catalog, PDF, 3MB


MH No. Compound Name Indication Order
M-904 Pramipexole Dopamine receptor agonist; used to treat Parkinson's disease, restless legs syndrome
E-902 Escitalopram oxalate Serotonin 5-HT reuptake inhibitor, antidepressant, antixiolytic
O-902 Oxcarbazepine An anticonvulsant used to treat seizures in patients with epilepsy
M-905 Mirtazapine Serotonin & noradrenergic antagonist, an antidepressant used to treat severe depression
L-902 Lamotrigine Voltage-sensitive sodium channel inhibitor, an anticonvulsant used to treat seizures and bipolar disorder.
V-901 Venlafaxine Serotonin and norepinephrine reuptake inhibitor used to treat major depressive disorders, generalized anxiety disorder , panic disorder, social phobia, and chronic pain
A-907 Aripiprazole An atypical antipsychotic used to treat schizophrenia and bipolar mania, acting on dopamine and serotonin receptors
D-908 Duloxetine hydrochloride Serotonin & norepinephrine reuptake inhibitor, used to treat major depressive disorder, generalized anxiety disorder, fibromyalgia, neuropathic pain
B-903 Bupropion hydrochloride Dopamine & norepinephrine reuptake inhibitor, nicotine receptor antagonist, used as an antidepressant and smoking cessation therapy
R-903 Ropinirole hydrochloride Dopamine D2, D3, D4 receptor agonist used to treat treat Parkinson's disease and restless legs syndrome
S-909 Sertraline hydrochloride Serotonin reuptake inhibitor; used to treat used to treat major depressive disorder, obsessive–compulsive disorder, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder, and social anxiety disorder
P-902 Paroxetine hydrochloride A serotonin reuptake inhibitor with antidepressant and anxiolytic properties.
Z-903 Ziprasidone hydrochloride Dopamine D2 , Serotonin 5-HT2A, 5HT1D receptor antagonist, 5-HT1 receptor agonist; an atypical antipsychotic used to treat schizophrenia and bipolar disorder.
G-901 Gabapentin Gamma aminobutyric acid (GABA) analog, anticonvulsant used to treat partial seizure, neuropathic pain, hot flashes, and restless legs syndrome.
D-909 Donepezil Reversible acetylcholinesterase inhibitor, used to treat Alzheimer's disease
C-916 Coenzyme A-S-acetyl-7-hydroxynaphthylethylamine Ligand for melatonin rhythm enzyme arylalkylamine-N-acetyltransferase (AANAT).
C-915 Carnosine-d7 Use as LC/MS internal standard to quantify carnosine
A-908 Anserine-d4 Stable isotope labeled anserine
F-905 3-Fluoro-5-{2-[2-(fluoromethyl)thiazol-4-yl]ethynyl}benzonitrile Metabotropic glutamate mGluR5 PET ligand reference standard
B-904 3-{2-[2-(Bromomethyl)thiazol-4-yl]ethynyl}-5-fluorobenzonitrile Metabotropic glutamate mGluR5 PET imaging ligand precursor
D-910 N-Desmethylolanzapine Olanzapine metabolite
P-903 3-{2-[4-(6-Fluorobenzo[d]isoxazol-3-yl)-1-piperidyl]ethyl}-7-hydoxy-4-methyl-1,5-diazabicyclo[4.4.0]deca-3,5-dien-2-one Resperidone metabolite; atypical antipsychotic used to treat schizophrenia and schizoaffective disorder
T-910 Tianeptine, sodium salt Atypical agonist of the mu-opioid receptor used in the treatment of major depressive disorder, anxiety, asthma, and irritable bowel syndrome.
B-905 N-Bromoacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline Peripheral benzodiazepine receptor PET ligand labeling precursor
F-906 N-Fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline Peripheral benzodiazepine receptor PET ligand reference standard
R-905 N-(2-Aminoethyl)-5-(3-fluorophenyl)-4-thiazole carboxamide hydrochloride Serotonin 5-HT2, 5-HT3, and histamine 1 H1 receptor antagonist used an atypical antidepressant
H-909 N-(2-Hydroxybenzyl)-N-(4-phenoxypyridin-3-yl)acetamide Peripheral benzodiazepine receptor PET imaging ligand precursor
M-907 N-(2-Methoxybenzyl)-N-(4-phenoxypyridin-3-yl)acetamide Peripheral benzodiazepine receptors PET imaging ligand reference standard
M-911 3-(6-Methyl-pyridin-2-ylethynyl)-cyclohex-2-enone O-Methyl-oxime Metabotropic glutamate mGluR5 antagonist
M-912 3-(6-Methyl-pyridin-2-ylethynyl)-cyclohex-2-enone oxime mGlu5 receptors PET imaging ligand precursor
M-908 (±)-2-[Di(phenyl)methanesulfinyl]acetamide Dopamine reuptake inhibitor with wakefulness-promoting activity
M-909 R-(–)-[2-(Diphenyl)methanesulfinyl]acetamide Dopamine reuptake inhibitor; (R)-(-) enantiomer of Modafinil with a longer duration of action and increased wakefulness promoting activity
M-910 S-(+)-[2-(Diphenyl)methanesulfinyl]acetamide (S)-(+) enantiomer of Modafinil
M-913 2-[4’-(Methylamino)phenyl]-6-hydroxybenzothiazole Aggregated amyloid protein ligand; thioflavin-T analog; PET imaging agent Pittsburgh Compound-B (PIB) reference standard.
A-909 2-(4’-Aminophenyl)-6-methoxymethoxybenzothiazole beta-amyloid plaque PET imaging agent [Pittsburgh Compound-B (PIB)] precursor
A-911 6-Aminomethyl-3-methyl-4H-1,2,4-benzothiadazine-1,1-dioxide hydrochloride Taurine antagonist
A-910 (2S,3S,4R,5R,E)-N-Ethyl-3,4-dihydroxy-5-(6-(4-(6-(2-(4-(2-(4,4-difluoro-4,4a-dihydro-5-(thiophen-2-yl)4-bora-3a,4a-diaza-s-indacene-3-yl)vinyl)phenoxy)acetamido)hexanamido)butylamino)-9H-purin-9-yl)-tetrahydrofuran-2-carboxamide (ABEA-X-BY630) Red-emitting fluorescent adenosine A3 receptor agonist
D-912 2-{4-[4-(2-Hydroxyphenyl)piperazin-1-yl]butyl}-4-methyl-1,2,4-triazine-3,5-(2H,4H)-dione 5-HT1A receptor PET imaging ligand precursor
C-917 2-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl}-4-methyl-1,2,4-triazine-3,5-(2H,4H)-dione 5-HT1A receptor PET imaging ligand reference standard
B-906 8-Bromo-6-phenyl-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylic acid ethyl ester Benzodiazepine intermediate for preparation of novel anxiolytic agent
M-914 1-(2-Methylbenzoxazol-6-yl)-3-[1,5]-naphthyridin-4-yl-urea Orexin subtype 1 antagonist
I-905 2-Isopropylpentanoic acid Non-teratogenic constitutional isomer of the anticonvulsant drug valproic acid
S-910 (R)-5,6-Dihydro-5-(methylamino)-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one maleate Dopamine D2 receptor agonist
D-914 (+)-(2R,3R,11bR)-10-Methoxy-3-(2-methylpropyl)-9-[11-(2,4,6-triethynylphenoxy)undecyloxy]- 1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-ol Dihydrotetrabenazine derivative for preparation of magnetic resonance imaging (MRI) agent.
C-918 3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide Metabotropic glutamate mGluR5 positive allosteric modulator
B-907 N-benzo[1,3]dioxol-5-yl-2-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H purin-8-yl)-1-methyl- 1H-pyrazol-3-yloxy]acetamide A2B adenosine receptor antagonist
M-915 5-[(6-{[(5a,6a)-7,8-Didehydro-4,5-epoxy-3-hydroxy-17-methylmorphinan-6-yl]oxy}hexyl)- disulfanyl]-2-nitrobenzoic acid Morphine derivative for preparation of protein disulfide conjugate
N-903 2-Amino-1-(3,4-ditrimethylacetoxyphenyl)ethanol hydrochloride Dipivalyl derivative and prodrug of norepinephrine
F-907 2-Amino-1-(3,4-ditrimethylacetoxy-6-fluorophenyl)ethanol hydrochloride Dipivalyl derivative and prodrug of 6-fluoronorepinephrine
A-912 (Sp)-Adenosine 3',5'-cyclic monophosphorothioate triethylammonium salt Protein kinase A agonist
B-909 DL-threo-ß-Benzyloxyaspartic acid Excitatory amino acid transporters inhibitor
S-911 SKF-83566 hydrobromide Dopamine D1 receptor antagonist
B-912 {(R,S)-[(S)-1-(4-Bromophenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl}phosphonic acid hydrochloride NMDA receptor antagonist
D-917 (R)-(+)-a-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol Serotonin 5-HT2A receptor antagonist
A-917 (3-Aminopropyl)(diethoxymethyl)phosphinic acid GABAB receptor antagonist
P-904 Phenazepam GABAA receptor allosteric modulator used to treat psychiatric schizophrenia and anxiety
B-913 Bromazepam GABAA receptor allosteric modulator, a benzodiazepine derivative drug for the treatment of anxiety or panic attacks
E-903 Estazolam GABAA receptor allosteric modulator, a benzodiazepine derivative drug for the treatment of insomnia
A-918 4-Amino-1-tert-butyl-3-(1’-naphthylmethyl)pyrazolo[3,4-d]pyrimidine Tyrosine kinase inhibitor
S-912 N-(1-Methyl-1H-indol-5-yl)-N'-(3-methylisothiazol-5-yl)urea 5-HT2B receptor antagonist
P-905 Methyl (8-chloro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol[1,5-a][1,4]benzodiazepin-3-yl)methyl ether a5 GABAA receptor inverse agonist
C-921 4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide Selective cyclooxygenase-2 (COX-2) inhibitor
C-922 4-Chloro-2-(4,5-dihydro-1H-imidazol-2-yl)-2,3-dihydro-1H-isoindole Hydroiodide I2 imidazoline receptor ligand
D-920 Delorazepam Active metabolite of the benzodiazepine drugs diclazepam and cloxazolam, GABAA receptor allosteric modulator, anxiolytic, skeletal muscle relaxant, hypnotic and anticonvulsant
P-906 (+)-(4aR,10bR)-3,4,4a,5,6,10b-Hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol hydrochloride Dopamine D2/3 receptor agonist; PET ligand reference standard.
D-919 (+)-(4aR,10bR)-3,4,4a,5,6,10b-Hexahydro-2H-naphtho[1,2-b]-1,4-oxazine-9-ol hydrochloride Dopamine D2/3 receptors PET ligand labeling precursor
N-905 (-)-(2S,4R)-1-{(3R)-5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl}-4-hydroxy-N,N-dimethyl-2-pyrrolidine-carboxamide Orally-active non-peptide vasopressin V1b receptor antagonist
C-924 N-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide Dopamine D4 receptor PET ligand precursor
C-925 N-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-hydroxybenzamide Dopamine D4 receptor PET ligand labeling precursor
B-914 Benperidol Dopamine D2 receptor antagonist, antipsychotic, neuroleptic, treatment for hypersexuality syndromes
M-917 N-Methylbenperidol Antipsychotic; dopamine D2 receptors PET ligand reference standard
M-918 (RS)-1-[3-(Trimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenofuran-5-carbonitrile iodide Peripherally restricted selective serotonin reuptake inhibitor
D-921 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride Sigma-1 receptor agonist
D-922 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-N-methyl-2,2-diphenylbutanamide hydrochloride Loperamide metabolite, P-glycoprotein PET reagent reference standard, P-glycoprotein inhibitor
B-915 (1-Butylpiperidin-4-yl)methyl 4-amino-3-methoxybenzoate Serotonin 5-HT4 receptor agonist
B-916 (1-Butylpiperidin-4-yl)methyl 4-amino-3-hydroxybenzoate Serotonin 5-HT4 receptor agonist
V-903 2-Ethyl-3-methylvaleramide Structural isomer of valpromide, a valproic acid prodrug; valnoctamide is not biotransformed into its homologous acid, valnoctic acid, in vivo; used as a sedative-hypnotic.
M-919 4-[2-(Methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide hydrochloride 5-HT7 receptor agonist
N-906 4-Nitrophenyl-4-[bis(1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate Monoacylglycerol lipase (MAGL) inhibitor
H-910 N-[2-(5-Hydroxy-6-fluoro-1H-indol-3-yl)ethyl]-2-oxopiperidine-3-carboxamide (6-Fluoro-HIOC) Fluorinated HIOC derivative; selective TrkB receptor agonist; neuroprotectant
T-911 N-[2-(2-Trifluoromethyl-5-hydroxy-1H-indol-3-yl)ethyl]-2-oxopiperidine-3-carboxamide Fluorinated HIOC derivative
V-904 5-{4-[4-(5-Cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide dihydrochloride Selective serotonin reuptake inhibitor and 5-HT1A receptor partial agonist, used to treat major depressive disorder.
B-917 Buprenorphine hydrochloride High affinity partial mu-opioid receptor agonist, used to treat opioid use disorder, acute pain, and chronic pain
C-927 (+)-6-((R)-2-{2-[4-(4-Chlorophenoxy)piperidin-1-yl]ethyl}pyrrolidine-1-sulphonyl)-1H-indole hydrochloride High-affinity, selective 5-HT7 antagonist
C-928 (-)-6-((S)-2-{2-[4-(4-Chlorophenoxy)piperidin-1-yl]ethyl}pyrrolidine-1-sulphonyl)-1H-indole Hydrochloride Isomer of 5-HT7 antagonist SB-656104-A.
C-929 Clozapine-N-oxide Clozapine metabolite, DREADD ligand
L-904 2-(6-Fluoro-1H-indol-3-yl)-N-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)ethanamine hydrochloride Selective 5­HT6 receptor antagonist
L-905 9-Isopropyl-N-[3-(trifluoromethyl)benzyl]-9H-purin-6-amine CK1, ERK2 and CDK7 kinases inhibitor that results in a lengthening of circadian periods
L-906 N-(1-(4-Iodobenzyl)piperidin-4-yl)-3-chlorophenylacetamide Selective sigma-1 receptor ligand
S-913 2-Bromo-N-[4-chloro-3-[[(3R)-1-methyl-3-pyrrolidinyl]oxy]phenyl]-4,5-dimethoxybenzenesulfonamide Selective urotensin-II (UT) receptor antagonist
A-919 (±)-3-(4-Chlorophenyl)-3-[2-(dimethylamino)ethyl]-3,4-dihydro-1H-2-benzopyran-1-one hydrochloride Non-peptide selective urotensin-II (UT) receptor agonist
D-923 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-2,2-diphenylbutanamide Loperamide metabolite, P-glycoprotein PET ligand labeling precursor
P-907 N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide Selective fatty acid amide hydrolase (FAAH) inhibitor.
M-920 (+)-4-(2-methoxyphenyl)-3,7,7-trimethyl-2H,4H,5H,6H,7H,8H,9H-pyrazolo[3,4-b]quinolin-5-one Serine/threonine kinase glycogen synthase kinase-3 (GSK3) inhibitor
M-921 (-)-4-(2-methoxyphenyl)-3,7,7-trimethyl-2H,4H,5H,6H,7H,8H,9H-pyrazolo[3,4-b]quinolin-5-one Serine/threonine kinase glycogen synthase kinase-3 (GSK3) inhibitor.
D-924 [5-(3,4-Dimethoxyphenyl)-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl][4-(2-methoxyphenyl)-1-piperazinyl]-methanone An agent that enhances the amplitude of circadian activity and induces intracellular cAMP levels
B-918 1,3-Bis(8-acetyleno-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5a][1,4]benzodiazepine-3-carboxy)propyl diester Selective alpha5 GABA-A receptor antagonist/negative allosteric modulator
N-907 (±)-6-[(4-Chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl]-1Hbenzo[d][1,2,3] triazole New! Aromatase PET imaging ligand [11C]vorozole labeling precursor
B-919 (±)-trans-2-(4-Bromo-2,5-dimethoxybenzyl)-6-(2-methoxyphenyl)piperidine hydrochloride New! Selective agonist for serotonin 5-HT2A receptor over the 5-HT2C receptor
N-908 (R)-6-[(4-Chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl]-1H-benzo[d][1,2,3]triazole New! Aromatase PET imaging ligand [11C]vorozole labeling precursor
N-909 (S)-6-[(4-Chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl]-1H-benzo[d][1,2,3]triazole Aromatase PET imaging ligand [11C]vorozole labeling precursor
A-920 2-(5-{[3-(2-Aminoethyl)-1H-indol-5-yl]disulfanyl}-1H-indol-3-yl)ethan-1-amine dipicrate New! A disulfide analog of serotonin
V-905 [d(CH2)5(1), D-Tyr(2), Thr(4), Orn(8), des-Gly-NH2(9)]-Vasotocin TFA salt Selective oxytocin receptor antagonist
L-907 N-(4-(4-(4-Methoxyphenyl)-1,4-diazepan-1-yl)butyl)-4-(thiophen-3-yl)benzamide New! D3 dopamine receptor ligand
C-930 (2S)-2-Amino-4-(2-amino-4-chlorophenyl)-4-oxobutanoic acid (4-Cl-KYN) trifluoroacetate New! Prodrug of the glycine binding site NMDA receptor antagonist 7-chlorokynurenine
P-908 11-(1-Piperazinyl)-5H-dibenzo[b,e][1,4]diazepine (C21) Dihydrochloride New! DREADD ligand
C-931 N-{4-[4-(3-cyanophenyl)piperazin-1-yl]butyl}-4-(thiophen-3-yl)benzamide (MC-25-41) hydrochloride Hight-affinity, selective D3 dopamine receptor ligand.
D-925 Deschloroclozapine (DCZ) Dihydrochloride DREADD ligand
J-902 8-Chloro-11-(4-ethylpiperazin-1-yl)-4-fluoro-5H-dibenzo[b,e][1,4]diazepine (JHU37160) Dihydrochloride New! DREADD agonist with high affinity and potency for CNS applications.
P-909 1-Methyl-7,8,9,10-tetrahydro-1H-6,10-methanoazapino[4,5-g]quinoxaline-2(6H)-one Hydrochloride (PSEM-792 HCl) New! Ultrapotent chemogenetic agent
P-910 2-Propoxy-7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline (PSEM-817) Hydrochloride New! Ultrapotent chemogenetic agent
T-912 8-methoxy-3-methyl-1H,2H,3H,4H,5H,6H-azepino[4,5-b]indole (Tabernanthalog) New! A non-hallucinogenic agonist of the serotonin 5-HT2A receptor
A-913 (Rp)-Adenosine 3',5'-cyclic monophosphorothioate triethylammonium salt Protein kinase A inhibitor
A-915 [5-Amino-1-(4-methoxyphenyl)sulfonylpyrazol-3-yl]benzoate NS3 West Nile virus protease inhibitor
A-904 (R)-(-)-2-Amino-5-phosphonopentanoic acid anticonvulsant; potent & selective NMDA receptor antagonist
H-906 7alpha-(16-hydroxyhexadecyl)estra-1,3,5-trien-3,17beta-diol Estrogen receptor modulator
T-909 7alpha-[(3R/S,7R,11R)-3,7,11,15-tetramethylhexadecyl]estra-1,3,5-trien-3,17beta-diol none
H-905 7alpha-hexadecylestra-1,3,5-trien-3,17beta-diol Estrogen receptor modulator
C-711 Coenzyme A-S-acetyltryptamine Arylalkylamine N-acetyltransferase (AANAT) inhibitor
C-504 7-Acetoxychlorpromazine hydrogen maleate Putative chlorpromazine metabolite
A-508 Acetoxyethyldimethylethylammonium iodide Acetylcholine analog
B-807 N-Acetyl-2-benzyltryptamine Melatonin receptor antagonist
D-523 N-Acetyl-3,4-dihydroxy-beta-phenethylamine Dopamine metabolite
P-701 N-Acetyl-3-hydroxy-4-methoxy-beta-phenethylamine Dopamine derivative
P-703 N-Acetyl-4-methoxy-beta-phenethylamine Phenethylamine derivative
O-502 N-Acetyl-DL-octopamine Metabolite of biogenic amines
A-906 d7-N-Acetylserotonin Stable isotope labeled melatonin MT1, MT2, and MT3 receptor agonist
A-901 N-Acetyltyramine Biogenic amine, DOPA oxidase inhibitor
A-903 ADAM dDihydrochloride Serotonin transporter ligand
P-518 N-(2-Adamantyl)piperazine dihydrochloride Potential psychotropic
A-502A Adapiperazine dihydrochloride Dopamine receptor antagonist, antiemetic, antipsychotic agent
A-804 N-(beta-Alanyl)-L-DOPA trifluoroacetate DOPA analog
A-805 N-(beta-Alanyl)tyrosine trifluoroacetate Bicyclic cage-like metal chelator
A-512 Alanylalanyl-6-hydroxydopamine hydrochloride Analog of 6-Hydroxydopamine, a neurotoxin used to induce Parkinson's disease
A-902 N-beta-Alanyldopamine hydrochloride DOPA analog, sclerotin precursor
A-703 Allantoxanamide Uricase inhibitor
A-510 2-Amino-1-(3,4,5-trimethoxyphenyl)ethanol Mescaline/Amphetamine analog as possible hallucinogen or psychomimetic
A-511 2-Amino-1-(3,4-dimethoxyphenyl)ethanol hydrochloride Mescaline/Amphetamine analog as possible hallucinogen or psychomimetic
A-514 6-Amino-2-chloro-9-(2'-O-methylsulfonyl-beta-D-xylofuranosyl)-9H-purine Anticancer, thymidine monophosphate kinase inhibitor
M-801 (S)-2-Amino-2-methyl-4-phosphonobutanoic acid Metabotropic glutamate mGluR2/3 agonist
C-535 3-Amino-3,4-dihydro-7-hydroxycarbostyril
H-525 2-Amino-4-hydroxy-beta-phenethylamine dihydrobromide beta-phenethylamine derivative
I-707 2-(3-Amino-4-iodophenoxy)methylimidazoline dihydrochloride Imidazoline-guaninidine binding site (IGRS) ligand, PET tracer precursor
A-803 (RS)-1-Amino-5-phosphonoindan-1-carboxylic acid Rigid MPPG analog; selective group II metabotropic glutamate receptor antagonist
T-510 2-Amino-DL-tyrosine Tyrosine analog
P-706 6-[2-(4-aminophenyl)ethyl-propylamino]-5,6,7,8-tetrahydronaphthalen-1-ol Fluorescent ligand for dopamine receptors
A-503 3-(2'-Aminobenzhydryloxy)tropane Muscarinic M1 receptor ligand
A-701 cis-3-Aminocyclohexanecarboxylic acid Selective neuronal GABA uptake inhibitor
A-504 3-(beta-Aminoethyl)-5-hydroxybenzo[b]thiophene Serotonin 5-HT1E ligand
A-801 (RS)-1-Aminoindan-1,5-dicarboxylic acid Metabotropic glutamate mGluR1 antagonist
N-701 p-Aminophenethylspiperone Dopamine D2 receptor antagonist; intermediate for photoaffinity agents
I-706 2-(3-Aminophenoxy)methylimidazoline dihydrochloride Imidazoline-guaninidine binding site (IGRS) ligand, PET tracer precursor
S-704 (±)-1-(4'-Aminophenyl)-7-bromo-8-methoxy-3-methyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine Dopamine D1 receptor antagonist alkylating ligand precursor
T-504 1-[2-(4-Aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine dihydrochloride Serotonin 5-HT1A receptor agonist
M-502 (±)-3-(2-Aminopropyl)-5-methoxyindole hydrochloride Serotonin analog
A-505 2-Aminotetralin hydrochloride Serotonin 5-HT1A ligand
A-507 5-Aminotryptamine dipicrate Serotonin 5-HT1A receptor agonist
A-905 Aniracetam D2/D3, nACh, & 5-HT2A receptor ligand, antidepressive agent; nootropic agent
A-704 APEC bis(trifluoroacetate) Adenosine A2 receptor ligand
A-705 p-Aminophenylacetyl-APEC Functionalized adenosine A2 ligand.
A-914 Asenapine maleate Serotonergic, dopaminergic, and adrenergic receptor ligand, antipsychotic agent
A-806 Autonomium iodide A natural product from sponge with a dual adrenergic and cholinergic properties
Y-708 (±)-4-Azido-5-deschloro-YM-09151-02 hydrochloride Reference standard for YM-09151-2 analogs
Y-704 (±)-4-Azido-5-iodo-YM-09151-2 dihydrochloride Dopamine D2 receptor photoaffinity ligand
A-506 1-[2-(4-Azidophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine hydrochloride Serotonin 5-HT1A receptor photoaffinity labeling probe
B-701 N-[1-(2-Benzo[b]thiophenyl)cyclohexyl]piperidine hydrochloride Dopamine uptake inhibitor with little affinity for PCP sites
D-511 4'-Benzyloxy-2-dibenzylaminopropiophenone Beta-phenylethylamine derivative
P-517 4-Benzyloxy-3-methoxypyruvic acid Pyruvic acid derivative
C-505 8-Benzyloxy-7-methoxychlorpromazine Chlorpromazine analog
D-906 FITC-APEC Fluorescent adenosine A2a receptor ligand
B-139 (E)-7-Benzylidene-7-dehydronaltrexone hydrochloride selective non-peptide delta1 opioid receptor antagonist
S-703 (±)-7-Bromo-1-[4'-(2-chloroethyl)aminophenyl]-8-hydroxy-3-methyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine dihydrobromide Dopamine D1 receptor alkylating ligand
C-705 (±)-7-Bromo-1-[4’-bis(2-chloroethyl)aminophenyl]-8-hydroxy-3-methyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine hydrochloride Dopamine D1 receptor alkylating ligand
B-806 1-Bromo-2,5-bis(4-hydroxystyryl)benzene Amyloid imaging probe
B-910 1-[4-(6-Bromo-benzo[1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]-ethanone GPR30 (GPER1) agonist
B-911 4-(6-Bromo-benzo[1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline GPR30 (GPER1) antagonist
B-802 N-Bromoacetyl-beta-phenethylamine Cysteine-reactive ligand, alkylating reagent
B-801 N-Bromoacetylnaphthalene-2-ethylamine Cysteine-reactive ligand, alkylating reagent
B-803 N-Bromoacetyltryptamine Cysteine-reactive ligand, alkylating reagent; reversible inhibitor of melatonin secretion in the pineal gland.
Q-707 N-(tert-Butyloxycarbonyl)-6-nitro-5-(trimethylstannyl)quipazine Radioiodinated 5-HT uptake inhibitor precursor
A-513 N-(tert-Butyloxycarbonyl)alanylalanyl-6-hydroxydopamine Analog of 6-Hydroxydopamine, a neurotoxin used to induce Parkinson's disease
C-501 10-Carboethoxy-2-chlorophenothiazine Cholinesterase Inhibitor
C-148 (-)-2-beta-Carbomethoxy-3-beta-(4-iodophenyl)tropane D-tartrate Dopamine reuptake inhibitor
C-801 (2S,1'S,2'S)-2-(Carboxycyclopropyl)glycine Metabotropic glutamate mGluR2 receptor agonist
C-105 CGS 19755 Competitive NMDA receptor antagonist; anticonvulsant and anti-ischemic
C-901 CGS 21680 hydrochloride Adenosine A2 receptor agonist
P-503 2-Chloro-10-(2-dimethylaminoethyl)phenothiazine hydrochloride Chlorpromazine analog
P-504 2-Chloro-10-(3-dimethylamino-2-hydroxypropyl)phenothiazine hydrogen maleate Chlorpromazine analog
C-536 6-Chloro-2-methylmelatonin Melatonin receptor antagonist
D-524 DL-2-Chloro-3,4-dihydroxyphenylalanine Hydrobromide L-DOPA analog
D-525 DL-6-Chloro-3,4-dihydroxyphenylalanine hydrobromide L-DOPA analog
D-518 DL-3-Chloro-4,5-dihydroxyphenylalanine hydrobromide beta-Phenylalanine derivative
C-802 (RS)-2-Chloro-5 hydroxyphenylglycine Metabotropic glutamate mGlu5 receptor agonist
P-505 2-Chloro-6,9-dioxophenothiazine Possible chlorpromazine metabolite
P-506 (±)-2-Chloro-7,8-dioxo-10-(3-dimethylamino-2-hydroxypropyl)phenothiazine hydrochloride Possible chlorpromazine metabolite
C-708 Chloro-IB-MECA Adenosine A3 agonist with potential antineoplastic activity
I-501 3-Chloro-N-desmethylimipramine hydrochloride Antidepressant
A-509 N-(3-Chlorophenyl)-N-[gamma-N',N'-dimethylaminopropyl]aniline hydrochloride Inhibitor of dopamine activated adenylase cyclase cAMP phosphodiesterase
C-538 DL-p-Chlorophenylalanine Selective and irreversible inhibitor of tryptophan hydroxylase
C-537 2-Chloropropadrine hydrochloride Vasoconstrictor
C-806 Chlorphentermine hydrochloride Serotonergic appetite suppressant of the amphetamine family
C-503 Chlorpromazine hydrochloride Dopamine, 5-HT, histamine, adrenaline, & muscarinic receptor antagonist, antipsychotic, antiemetic
C-529 nor1-Chlorpromazine hydrochloride Chlorpromazine metabolite
C-530 nor2-Chlorpromazine hydrochloride Active metabolite of chlorpromazine
C-526 Chlorpromazine sulfone hydrochloride Chlorpromazine metabolite
C-524 Chlorpromazine sulfoxide hydrochloride Antiemetic; antipsychotic agent; dopamine antagonist
C-532 nor1-Chlorpromazine sulfoxide hydrochloride Chlorpromazine metabolite
C-531 nor2-Chlorpromazine sulfoxide hydrochloride Chlorpromazine metabolite
C-701 Chlorpromazine-10-spermidine Dihydrochloride Potential prodrug for polyamines
C-525 Chlorpromazine-N-oxide Antiemetic; antipsychotic agent; dopamine antagonist
C-707 Chrysamine G beta-Amyloid ligand
C-908 Ciproxifan Histamine H3 receptor antagonist
C-904 Clopidogrel hydrogen sulfate Irreversible purinergic P2Y12 receptor inhibitor with antiplatelet activity
C-905 Clorgyline hydrochloride Antidepressant; monoamine oxidase inhibitor
C-807 Clozapine Selective dopamine D4 receptor antagonist, atypical antipsychotic used to treat schizophrenia
C-910 Coenzyme A-S-acetyl-2-naphthylen-1-ylethylamine Ligand for melatonin rhythm enzyme arylalkylamine-N-acetyltransferase (AANAT)
C-902 Coenzyme A-S-acetyl-L-DOPA DOPA conjugate
C-920 6-Cyano-7-nitroquinoxaline-2,3-dione Disodium Salt AMPA/kainate receptor antagonist
C-706 Cyanopindolol fumarate beta1-Adrenergic and 5-HT1A receptor antagonist
C-919 Cyclohexylcarbamic Acid 3’-Carbamoylphenyl-3-yl Ester Fatty-acid amide hydrolase (FAAH) inhibitor
C-804 (RS)-alpha-Cyclopropyl-4-phosphonophenylglycine Metabotropic glutamate mGluR3 receptor antagonist
C-702 5-(S)-Cysteinyl-L-DOPA melanoma biomarker
C-903 5-(S)-Cysteinyl-DOPAC hydrochloride Dopamine metabolite
C-805 5-(S)-Cysteinyldopamine May be involved in neural degeneration characteristic of Parkinson's disease; dopamine metabolite
D-803 DASB hydrochloride Serotonin transporter ligand, PET ligand precursor
Y-705 (±)-5-Deschloro-4-desmethyl-YM-09151-2 Precursor to radiolabeled 4-azido-5-iodo-YM-09151-2
T-902 (+)-(2R,3R,11bR)-9-O-Desmethyl-alpha-dihydrotetrabenazine Starting material for synthesis of carbon-11 labeled (+)-alpha-dihydrotetrabenazine ([11C]DTBZ)
D-804 Desmethyl-DASB DASB PET ligand precursor (cf. D-803)
N-704 (+)-N-Desmethyl-NNC 01-0112 hydrochloride NNC-01-0112 PET ligand precursor
T-511 N-Desmethyltriflupromazine hydrochloride Chlorpromazine analog
P-520 3,4-Di(beta-dimethylaminoethoxy)-beta-phenethylamine trihydrochloride
D-521 3,4-Di(beta-trimethylammoniumethoxy)-beta-phenethylamine Dichloride Hydrochloride Dopamine derivative
C-506 7,8-Diacetoxychlorpromazine hydrogen maleate Chlorpromazine analog
P-519 1,4-Diacryloylpiperazine Cross-linking monomer for development of polyacrylamide gels
Q-901 2-[2-(4-Dibenzo[b,f][1,4]thiazepine-11-yl-1-piperazinyl)ethoxy]ethanol fumarate Dopamine, serotonin, & adrenergic antagonist; antihistaminic, an atypical antipsychotic medication used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder.
D-514 L-3,4-Dibenzoyloxyphenylalanine Inhibitor of monoamine oxidase and the synaptosomal uptake of dopamine
P-514 2,4-Dibenzyloxy-5-methoxyphenylacetic acid
P-521 3,4-Dibenzyloxy-beta-phenethylamine hydrochloride Dopamine derivative
C-508 7,8-Dibenzyloxychlorpromazine Chlorpromazine analog
D-702 3-(4',4''-Dibromobenzhydryloxy)tropane hydrochloride Dopamine uptake inhibitor
D-802 (2S,1'R,2'R,3'R)-2-(2',3'-Dicarboxylcyclopropyl)glycine Anticonvulsant; selective group II mGluR agonist
B-711 2',4'-Dichlorobenzamil hydrochloride Sodium/calcium exchanger inhibitor
B-710 3',4'-Dichlorobenzamil hydrochloride Sodium/calcium exchanger inhibitor
D-529 2,4-Dichloropromazine hydrochloride Chlorpromazine analog
I-502 N,N-Didesmethylimipramine hydrochloride Imipramine metabolite
R-501 1-(beta-Diethylamino)ethylreserpine dipicrate Anticancer and hypotensive agent
D-522 3,4-Diethylcarbonato-beta-phenethylamine carbamate Dopamine derivative
D-904 d2-Dihydroouabain Stable isotope labeled dihydroouabain
D-905 (-)-alpha-Dihydrotetrabenazine Optical isomer of putative tetrabenazine metabolite alpha-dihydrotetrabenazine
T-802 (+)-alpha-Dihydrotetrabenazine Active metabolite of tetrabenazine with high affinity for the vesicular monamine transporter (VMAT2)
D-701 (±)-5,6-Dihydroxy-2-(N,N-dimethyl)aminotetralin hydrobromide Dopamine analog
D-519 2,3-Dihydroxy-beta-phenethylamine hydrobromide Positional isomer of dopamine
D-520 2,4-Dihydroxy-beta-phenethylamine hydrochloride Positional isomer of dopamine
C-512 7,8-Dihydroxy-N,N-didesmethylchlorpromazine hydrochloride Chlorpromazine analog
H-512 DL-2-(3,4-Dihydroxybenzyl)-2-hydrazinopropionic Acid Aromatic-l-amino-acid decarboxylase inhibitor, used in Parkinson's Disease to reduce peripheral adverse effects of Levodopa
C-511 7,8-Dihydroxychlorpromazine hydrochloride Chlorpromazine analog
D-509 5,6-Dihydroxyindole Catechol O-methyltransferase (COMT) inhibitor, dopamine metabolite
P-501 7,8-Dihydroxyperphenazine dihydrochloride Chlorpromazine metabolite
S-501 D-(+)-threo-3-(3,4-Dihydroxyphenyl)serine Monoamine oxidase inhibitor
S-502 L-(-)-threo-3-(3,4-Dihydroxyphenyl)serine
D-515 (+)-2,4-Dihydroxyphenylalanine Enantiomer of L-DOPA
D-517 (-)-2,4-Dihydroxyphenylalanine Tyrosinase inhibitor
D-512 (±)-2,4-Dihydroxyphenylalanine Racemic mixture of L-DOPA, the precursor to the neurotransmitters dopaminem, norepinephrine, and epinephrine
D-516 DL-3,4-Dihydroxyphenylalanyl-GABA GABA adduct
D-505 3,4-Dihydroxyphenylethanol,1,4-Diazabicyclo[2.2.2]octane salt Naturally occurring phenolic phytochemical with potential antioxidant, anti-inflammatory and cancer preventive activities
D-506 3,4-Dimethoxy-5-hydroxybenzoic acid Thiopurine methyltransferase inhibitor
P-522 2,5-Dimethoxy-beta-phenethylamine hydrochloride Phenethylamine derivative
C-513 7,8-Dimethoxychlorpromazine hydrochloride Chlorpromazine analog
D-916 3-(2,5-Dimethoxyphenyl)-6-(3,4-dimethoxy¬phenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine Phosphodiesterase type 4 (PDE4) inhibitor
P-515 2,4-Dimethoxyphenylacetic acid Dopamine analog
D-528 DL-(N,N-Dimethyl)ephedrine iodide Choline acetyltransferase inhibitor
F-902 N,N-Dimethyl-2-(2-amino-4-fluorophenylthio)benzylamine Serotonin transporter PET ligand reference standard
D-507 alpha-Dimethylamino-3,4-dihydroxyacetophenone methachloride Quarternary trimethylammonium salt related to dopamine and noradrenaline
I-902 2-(4’-N,N-Dimethylaminophenyl)-6-(tributylstannyl)imidazo[1,2-a]pyridine Radio-iodinated IMPY precursor
I-901 2-(4’-N,N-Dimethylaminophenyl)-6-iodoimidazo[1,2-a]pyridine Beta-amyloid aggregate-specific ligand, PET tracer precursor
D-915 2-(3-Dimethylaminophenyl)-7,8-dihydroxy-4H-chromen-4-one Tropomyosin-related kinase (TrkB) agonist
D-513 4-(gamma-N,N-Dimethylaminopropylamino)phenol Dimaleate Antiozonant
H-518 N,N-Dimethylhistamine methiodide Histamine derivative
I-705 1,2-Dimethylisoquinolinium iodide
C-514 7,8-(Dimethylmethylenedioxy)chlorpromazine Chlorpromazine analog
C-907 N,N-Dinorcitalopram oxalate Citalopram metabolite
C-516 7,8-Dioxo(N,N-didesmethyl)chlorpromazine hydrochloride Chlorpromazine analog
C-515 7,8-Dioxochlorpromazine hydrochloride Chlorpromazine analog
D-805 1,2-Dithiole-3-thione Antineoplastic agent
B-705 (R)-(+)-5-(1,3-Dimethylbutyl)-5-ethylbarbituric Acid Sedative, hypnotic
B-704 (S)-(-)-5-(1,3-Dimethylbutyl)-5-ethylbarbituric Acid Sedative, hypnotic
D-901 L-DOPA-ring-d3 Stable isotope labeled l-DOPA.
G-502 Dopamine-4-O-beta-D-glucuronide
D-504 Dopamine-4-O-sulfate Dopamine metabolite
E-704 EHPG piperazine salt Catecholamine turnover biomarker
E-709 (E)-2-Enevalproate, sodium salt Valproic acid metabolite
E-708 (E)-2-Enevalproic Acid Anticonvulsant; valproic acid metabolite
E-703 Epidepride Dopamine D2 receptor antagonist, precursor of PET tracer
C-502 N-Ethyl-2-chlorophenothiazine Cholinesterase inhibitor
T-506 5-Ethyl-5-(1'-methyl-3'-hydroxybutyl)-2-thiobarbituric Acid Thiopental metabolite
B-501 5-Ethyl-5-(3’-hydroxy-1’-methylbutyl)barbituric Acid Pentobarbitol metabolite
E-706 DL-alpha-Ethylmethionine-(S,R)-sulfoximine Glutamate synthetase inhibitor
E-701 N-Ethylnornicotine Nicotine analog, internal standard for mass spectrometry
F-901 FK866 Nicotinamide phosphoribosyltransferase inhibitor
N-502 6-Fluoronorepinephrine oxalate alpha-and beta-Adrenergic receptor agonist
F-908 1-(2-(4-(1-(4-Fluorophenyl)-5-(1-methyl-1H-1,2,4-triazol-5-yl)-1H-indol-3-yl)-1-piperidinyl)ethyl)imidazolidin-2-one alpha1-Adrenoceptor antagonist; a1-adrenoceptor PET ligand reference standard
F-909 1-(2-(4-(1-(4-Fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indol-5-yl)-1-piperidinyl)ethyl)imidazolidin-2-one alpha1-Adrenoceptor PET ligand labeling precursor
F-132 (±)-Fluoxetine Hydrochloride Serotonin uptake inhibitor; second-generation antidepressant
G-801 GBR 12909 dihydrochloride Dopamine reuptake inhibitor with behavioral effects similar to cocaine
G-501 gamma-Glutamyldopamine Kidney-specific prodrug of L-DOPA and dopamine
G-802 gamma-L-Glutamylserotonin Serotonin derivative
M-903 [(-)-(R)-Methyl 4-[(3,4-dichlorophenyl)acetyl]-3-[(1-pyrrolidinyl)methyl]-1-piperazinecarboxylate fumarate Kappa-opioid receptor agonist
H-520 2-Hydrazino-3-(4-hydroxyphenyl)propionic acid Potential antipsychotic; competitive inhibitor of fungal tyrosinase
B-804 N-[2-(7-Hydroxy-1-naphthyl)ethyl]-2-bromoacetamide Cysteine-reactive ligand, alkylating reagent, N-acetyltransferase (AANAT) inhibitor
H-903 N-[2-(7-hydroxy-1-naphthyl)ethyl]amine hydrochloride Serotonin N-acetyltransferase inhibitor
H-902 2-(5-Hydroxy-1H-indol-3-ylmethyl)thiazolidine-4-carboxylic Acid potassium salt Serotonin metabolite
H-904 6-Hydroxy-2-(4-hydroxyphenyl)-3-[(2E,6E)-3,7,11-trimethyl-dodeca-2,6,10-trienyl]-[1,4]-naphthoquinone Estrogen receptor modulator
R-701 17alpha-Hydroxy-20alpha-yohimban-16beta-(N-4-aminophenethyl)carboxamide dihydrochloride Adrenergic ?2 ligand radioiodination precursor
H-523 4(3)-Hydroxy-3(4)-(beta-dimethylaminoethoxy)-beta-phenethylamine Dihydrochloride beta-phenethylamine derivative
H-527 4(3)-Hydroxy-3(4)-(beta-trimethylammoniumethoxy)-beta-phenethylamine chloride hydrochloride beta-Phenethylamine derivative
H-515 beta-(5-Hydroxy-3-benzo[b]thienyl)-alpha-aminopropionic acid Inhibitor of DOPA decarboxylase
H-908 {4-[4-hydroxy-3-isopropyl-5-(4-nitrophenylethynyl)benzyl]-3,5-dimethylphenoxy}acetic acid beta-subtype selective thyroid hormone receptor antagonist
H-513 3-(4-Hydroxy-3-methoxyphenyl)-1-propanol Phenolic plant metabolite
P-528 (±)-4-Hydroxy-3-methoxyphenylpropyleneglycol 1,4-Diazabicyclo[2.2.2]octane lignin model compound
P-526 3-Hydroxy-4-methoxy-DL-phenylalanine Phenethylamine derivative
H-502 5-Hydroxy-6-methoxytryptamine creatinine sulfate 5-Hydroxytryptamine derivative
H-503 5-Hydroxy-7-methoxytryptamine creatinine sulfate 5-Hydroxytryptamine derivative
H-522 2-Hydroxy-beta-phenethylamine hydrochloride beta-phenethylamine derivative, Trace amine receptor 1 (TAAR1) ligand
H-701 (±)-7-Hydroxy-DPAT hydrobromide Selective D3 dopamine agonist
H-704 (R)-(+)-7-Hydroxy-2-(N,N-dipropylamino)tetralin hydrobromide Dopamine receptor antagonist
C-520 7-Hydroxy-N-desmethylchlorpromazine hydrochloride Chlorpromazine metabolite
I-504 2-Hydroxy-N-desmethylimipramine Tricyclic antidepressant; imipramine metabolite
H-705 (±)-trans-7-Hydroxy-PIPAT hydrochloride Dopamine D3 receptor agonist
H-521 3-Hydroxybenzylamine GABA receptor antagonist
C-518 7-Hydroxychlorpromazine hydrochloride Antiemetic; antipsychotic agent; dopamine antagonist
C-521 7-Hydroxychlorpromazine methiodide antiemetic; antipsychotic agent; dopamine antagonist
C-528 7-Hydroxychlorpromazine sulfoxide Chlorpromazine metabolite
C-519 7-Hydroxychlorpromazine-O-beta-D-glucuronide 7-hydroxychlorpromazine metabolite
D-501 6-Hydroxydopamine hydrobromide Catecholaminergic neurotoxin
D-502 6-Hydroxydopamine hydrochloride Catecholaminergic neurotoxin
C-803 7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate Ethyl Ester Metabotropic glutamate mGluR1 receptor antagonist
I-503 2-Hydroxyimipramine Imipramine metabolite
H-501 5-Hydroxyindole-3-beta-propionic acid GC/MS internal standard for catecholamine assay
H-516 3-(3-Hydroxyphenyl)-N-(n-propyl)piperidine hydrobromide Dopamine autoreceptor agonist, antiparkinson agent; dopaminergic agent
H-526 threo-beta-(4-Hydroxyphenyl)serine Phenylethanolamine derivative, potential quorum sensing inhibitor
H-901 4-Hydroxyphenylacetaldehyde Tyrosine metabolite
H-528 4-Hydroxyphenylglycol Octopamine metabolite
H-113 2-Hydroxysaclofen gamma-Aminobutyric acid GABAB antagonist
H-907 (Z)-4-Hydroxytamoxifen Estrogen receptor antagonist
H-504 4-Hydroxytryptamine creatinine sulfate 5-Hydroxytryptamine derivative
H-505 6-Hydroxytryptamine creatinine sulfate 5-Hydroxytryptamine derivative
H-510 4-Hydroxytryptophan hemiacetate Tryptophan derivative
I-801 IDAM hydrochloride Unlabeled analog of a SPECT serotonin transporter imaging agent
I-709 Inositol Phosphate, Arylbis(phosphonate) analog, dipotassium salt Non-hydrolysable inhibitor of myo-inositol monophosphatase
Q-708 5-Iodo-6-nitroquipazine Selective 5-HT uptake inhibitor
M-144 (+)-3-Iodo-MK-801 hydrochloride NMDA antagonist MK-801 analog
M-141 (-)-3-Iodo-MK-801 hydrochloride NMDA antagonist MK-801 analog
Y-706 (±)-4'-Iodo-YM-09151-02 Potential high affinity probe for dopamine D2 receptors
I-701 IsoMHPG Noradrenaline metabolite
I-906 (R)-2-Isopropylpentanoic acid (R)-enantiomer of non-teratogenic constitutional isomer of the anticonvulsant drug valproic acid.
I-907 (S)-2-Isopropylpentanoic Acid (S)-enantiomer of a non-teratogenic constitutional isomer of the anticonvulsant drug valproic acid
I-505 (±)-Isosalsoline hydrochloride Tetrahydroisoquinoline derivative active at TRPV receptors, monoamine oxidases A and B, and inhibits NO production
I-124 Isradipine Antihypertensive agent; calcium channel blocker; vasodilator
J-901 JMV-431 Neurotensin receptor subtype 2 agonist
K-501 Kawain Anticonvulsant; anxiolytic
K-701 Kemptide Fluorescein Fluorescently-labeled marker for protein kinase A (PKA)
L-901 beta-Lactotensin Neurotensin receptor subtype 2 agonist.
M-901 (+)-McN-5652 S-Desmethyl-S-butyryl ester D-tartrate (+)-McN-5652 PET ligand precursor
M-706 (+)-McN-5652 S-Desmethyl-S-butyryl ester (+)-McN-5652 PET ligand precursor
M-707 (+)-McN-5652 Serotonin transporter inhibitor (active enantiomer)
M-708 (-)-McN-5652 Serotonin transporter inhibitor (inactive enantiomer)
M-704 (±)-McN-5652 Serotonin transporter inhibitor
M-802 L-anti-endo-3,4-Methaneopyrrolidinedicarboxylic Acid Inhibitor of the Na-dependen, high-affinity synaptosomal Glu transporter
M-902 5-Methoxy-1-isopropyltryptamine oxalate Serotonin analog
M-501 1-(3-Methoxy-4-hydroxyphenyl)-1-hydroxy-2-aminopropane hydrogen oxalate Norepinephrine derivative
M-508 DL-3-Methoxy-alpha-methyl-DOPA-4-O-sulfate, potassium salt L-alpha-methyldopa derivative
C-523 7-Methoxychlorpromazine hydrochloride Chlorpromazine metabolite
M-506 6-Methoxymelatonin 6-hydroxymelatonin metabolite
P-509 2-Methoxyphenothiazine Phenothiazine derivative
M-503 6-Methoxytryptamine creatinine sulfate Serotonin derivative
I-703 (±)-1-Methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride Potential dopaminergic neurotoxin
M-804 (2S,3S,4S)-2-Methyl-2-(carboxycyclopropyl)glycine Metabotropic glutamate mGluR2 antagonist
P-511 N-Methyl-2-(trifluoromethyl)phenothiazine Phenothiazine derivative
M-701 1-Methyl-4-(2’-methylphenyl)pyridinium iodide 2'-methyl-MPTP metabolite, neurotoxin, vesicular monoamine transporter ligand
D-503 2-Methyl-6-hydroxydopamine hydrobromide Catecholaminergic neurotoxin
B-504 N-Methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide oxalate Muscarinic partial agonist (oxotremorine analog)
M-509 (±)-2-Methylamino-1-phenylethanol Monoamine oxidase A &B substrate
E-707 L-N-Methylepinephrine L-tartrate Epinephrine derivative
M-507 (R)-(-)-alpha-Methylhistamine 1.5 Oxalate Histamine H3 agonist
H-517 2-Methylhistamine dipicrate Histamine agonist
H-509 4-Methylhistidine hydrochloride Histidine analog
H-507 alpha-Methylhistidine hydrochloride Histidine decarboxylase inhibitor
I-704 1-Methylisoquinoline hydrochloride Potential dopaminergic neurotoxin
P-510 N-Methylphenothiazine Phenothiazine derivative
M-803 (RS)-alpha-Methylserine-O-phosphate Metabotropic glutamate mGluR antagonist
M-710 1-Methylserotonin hydrogen maleate Serotonin analog
M-504 alpha-Methylserotonin hydrogen oxalate Serotonin 5-HT2B agonist
M-709 1-Methyltryptamine hydrochloride Methylated tryptamine
M-711 5-Methyltryptamine hydrogen maleate Serotonin analog
M-712 6-Methyltryptamine hydrogen maleate Serotonin analog
M-510 N-Methyltyramine hydrobromide Human biogenic trace amine
M-703 Mifepristone Progesterone receptor antagonist; stimulates prolactin secretion
M-107 (+)-MK-801 hydrogen maleate Selective, non-competitive NMDA glutamate receptor antagonist
M-916 2-(4-Morphin-4-ylphenyl)-7,8-dihydroxy-4H-chromen-4-one 7,8-Dihydroxyflavone analog.
C-912 N-Caffeoylnorepinephrine Norepinephrine adduct
C-911 N-Cinnamoylnorepinephrine Norepinephrine adduct
C-913 N-Coumaroyldopamine Free radical scavenger, monoamine oxidase inhibitor, cholinesterase inhibitor
C-914 N-Coumaroyloctopamine Free radical scavenger, antioxidant, anti-inflammatory
F-903 N-feruloylnorepinephrine Norepinephrine derivative
F-904 N-Feruloyltyramine Alkaloid derivative in many natural products
T-702 (R)-(-)-N-Methyl-3-(2-iodophenoxy)-3-phenylpropanamine hydrochloride Norepinephrine transport inhibitor
N-801 (±)-N-Norfenfluramine hydrochloride Serotonin releaser, 5-HT2B agonist
N-802 (R)-(-)-N-Norfenfluramine hydrochloride Serotonin reuptake inhibitor
N-803 (S)-(+)-N-Norfenfluramine hydrochloride Serotonin uptake inhibitor
C-909 (R)-(+)-N-trans-p-Coumaroylnoradrenaline Plant metabolite implicated in tomato defense against pathogens
N-901 (±)-Nisoxetine hydrochloride Norepinephrine uptake inhibitor
N-705 6-Nitrodopamine Nitrated catecholamine
N-706 6-Nitronorepinephrine Nitrated catecholamine
N-703 (+)-NNC 01-0112 Dopamine D1 receptor ligand
N-904 R-(-)-Norapomorphine hydrobromide Dopamine receptor agonist and PET ligand labeling precursor
C-906 N-Norcitalopram oxalate Citalopram metabolite
N-702 (+)-Norepinephrine (+)-tartrate Unnatural enantiomer of norepinephrine
N-707 Norepinephrine-3-O-sulfate Catechol O-methyltransferase inhibitor
D-902 (±)-O-Desethylreboxetine Reboxetine PET ligand precursor
O-501 D-(-)-Octopamine Norepinephrine derivative, a biogenic amine formed by ?-hydroxylation of tyramine, found naturally in many plants, used as sympathomimetic drug
O-901 Olanzapine Dopamine and serotonin receptor inhibitor, an atypical antipsychotic used to treat schizophrenia and bipolar disorder
P-710 PD149163 Selective, brain penetrating neurotensin NTR1 receptor agonist with pro-cognitive, antipsychotic and anxiolytic effects. Neurotensin (8-13) analog.
P-512 Phenothiazine-5-oxide Phenothiazine matebolite
P-801 (±)-4-Phenyl-2-(propioamido)tetralin Melatonin receptor antagonist
P-804 (±)-4-Phenyl-2-[2',2',3'-2H]-(propioamido)tetralin Deuterated melatonin receptor antagonist
P-805 N-(1-benzylpiperidin-4-yl)-N-methyl-3-propan-2-yloxypyridin-2-amine dihydrochloride Dopamine D4 antagonist
P-513 nor1-Promazine sulfoxide hydrochloride Chlorpromazine metabolite
P-707 (R)-(+)-2-(N-Propargyl-N-propyl)amino-7-hydroxytetralin hydrochloride Radiolabeling (R)-(+)-7-hydroxy-DPAT precursor
P-708 (R)-(-)-2-(N-Propargyl-N-propyl)amino-8-hydroxytetralin Hydrochloride precursor to radiolabeled (R)-(Ð)-8-hydroxy-DPAT
D-041 (S)-(+)-N-Propylnorapomorphine hydrochloride Limbic-selective dopamine receptor antagonist
P-803 3-(R)-[2-(S)-(Pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide D2 allosteric modulator
R-902 (±)-Reboxetine mesylate Noradrenaline reuptake inhibitor used as an antidepressant
R-901 Risperidone Serotonin 5HT2 and dopamine D2 antagonist, an atypical antipscyhotic used to treat schizophrenia, bipolar disorder, and irritability associated with autism
R-702 5-Methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole hemisuccinate Serotonin 5-HT1A/1B agonist.
S-504 (±)-Salsoline hydrochloride Salsolinol metabolite; endogenous neurotoxin
S-505 (±)-Salsolinol hydrochloride Neurotoxic derivative of dopamine
S-803 Serotonin-O-beta-D-glucuronide Serotonin metabolite
S-503 Serotonin-O-sulfate Serotonin metabolite
S-905 SIB-1508Y alpha-4-beta-2 subtype selective neural nicotinic acetylcholine receptor agonist
S-903 SIB-1553A Nicotinic acetylcholine receptor agonist with selectivity for beta-4 subunit-containing receptors; possible cognitive enhancer
S-701 SKF-104078 Adrenergic alpha-2 antagonist
S-101 (R)-(+)-SKF-38393 hydrochloride D1 dopamine receptor agonist; active enantiomer of (±)-SKF-38393
S-906 SKF-81297 hydrobromide Dopamine D1 receptor agonist
S-907 SKF-82958 hydrobromide Dopamine D1 receptor agonist
S-904 SKF-83822 hydrobromide Dopamine D1 receptor agonist
S-706 SKF-83959 hydrobromide Dopamine D1 receptor agonist
S-901 Spiperone Serotonin 5-HT1A, 5-HT2A, 5-HT7, and dopamine D2 antagonist, a typical antipsychotic used to treat schizophrenia
S-705 SR 141716 Cannabinoid CB1 receptor inverse agonist used an anorectic anti-obesity drug
S-902 SR 142948 Neurotensin receptor antagonist
S-801 SR 144528 CB2 cannabinoid receptor inverse agonist
S-802 SR 48692 Neurotensin NT1 antagonist
S-908 SR147778 Cannabinoid CB1 receptor antagonist
A-702 N6-p-Sulfophenyladenosine triethylamine salt Water-soluble adenosine A1 agonist
T-905 (+)-Tetrabenazine Dopamine depleting agent; optical isomer of tetrabenazine
T-904 (-)-Tetrabenazine Dopamine depleting agent; optical isomer of tetrabenazine
T-901 (±)-Tetrabenazine Reversible monoamine depleting agent, used to treat chorea associated with Huntington's disease and hyperkinetic movement disorders.
I-702 1,2,3,4-Tetrahydroisoquinoline hydrochloride Potential dopaminergic neurotoxin
T-703 1-[1-(2-Thienyl)cyclohexyl]morpholine PCP analog
T-906 Thioperamide maleate CNS penetrant inhibitor of histamine H3 and H4 receptors
T-907 Tolcapone Nitrocatechol-type inhibitor of the enzyme catechol-O-methyltransferase (COMT) used to treat Parkinson's disease
B-901 trans-Bis-Q [trans-3,3'-bis[alpha-trimethylammonum)methyl]azobenzene dibromide] Photochromic acetylcholine receptor activator
A-808 Tributylstannyl-ADAM Radioiodinated ADAM precusor
T-501 Trifluoperazine-5-oxide Trifluoperazine metabolite
T-507 2,3,4-Trihydroxy-beta-phenylethylamine hydrochloride potential neurotoxin; arylsulfatase inhibitor
T-508 2,3,4-Trihydroxy-DL-phenylalanine Neurotoxic DOPA metabolite
H-511 5-(2,4,5-Trihydroxybenzyl)hydantoin
T-503 5,6,7-Trihydroxytryptamine creatinine sulfate Tryptamine derivative
D-510 5,6,7-Trimethoxy-N,N-dimethyltryptamine
P-516 3,4,5-Trimethoxyphenylacetic Acid Mescaline metabolite
M-145 (+)-3-Trimethylsilyl-MK-801 hydrochloride Radioiodinated (+)-3-iodo-MK-801 precursor
M-143 (-)-3-Trimethylsilyl-MK-801 hydrochloride Radioiodinated (-)-3-iodo-MK-801 precursor
Y-707 (±)-4'-Trimethylstannyl-YM-09151-02 Radioiodinated 4'-iodo-YM-09151-02 precursor
E-705 5-Trimethylstannylepidepride Precursor for radioiodinated epidepride (D2 antagonist)
T-908 7alpha-[(4R,8R)-4,8,12-Trimethyltridecyl]estra-1,3,5(10)-trien-3,17beta-diol A hybrid ligand of 17?-Estradiol and Vitamin E acting on estrogen receptor
U-802 Tritiated U-101,958 (N-methyl-3H)
T-704 Tropapride hydrochloride Dopamine D2 receptor antagonist
T-502 L-(-)-Tyrosine-O-sulfate potassium salt Tyrosine metabolite
U-703 (S)-(-)-N-Propargyl-UH-301 Hydrochloride Serotonin receptor antagonist radiolabel precursor
H-703 Velnacrine maleate Cholinesterase inhibitor
V-902 Ethyl 4-{2-[(2-methylbenzoyl)amino]ethylamino}piperidine-1-carboxylate hydrochloride Muscarinic M1 receptor allosteric modulator
W-501 N-(6-Aminocyclohexyl)-1-naphthalenesulfonamide hydrochloride Calmodulin antagonist
W-502 N-(6-Aminocyclohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride calmodulin antagonist
W-901 WAY 405 Serotonin 5-HT1A receptor antagonist
W-108 WAY-100635 maleate Serotonin 5-HT1A receptor antagonist
W-801 WRC-0571 Adenosine A1 receptor antagonist
Y-701 (±)-YM-09151-2 Dopamine D2 and D3 receptor antagonist and 5-HT1A receptor agonist, an atypical antipsychotic used to treat schizophrenia
Y-703 (+)-YM-09151-2 Active stereoisomer of YM-09151-2, Dopamine D2 and D3 receptor antagonist; 5-HT1A receptor agonist
Y-702 (-)-YM-09151-2 Inactive stereoisomer of YM-09151-2
Z-901 (±)-Zacopride hydrochloride Serotonin 5-HT3 receptor antagonist and 5-HT4 receptor agonist, used as antiemetic
Z-902 Zonisamide Anticonvulsant

About The Program

Since 1959, the NIMH Chemical Synthesis and Drug Supply Program has synthesized and distributed novel research chemicals, psychoactive drugs, and compounds that are unavailable from commercial sources to the scientific community working on research relevant to mental health.

Content © 2014. «RTI International».